2 Billion Dollars for Antibiotics!

The global pharmaceutical industry is being called on to pay for a 2 billion dollar innovation fund to find… better antibiotics.

We have noted before on NiB that there are very few new antibiotics in development, and that worldwide antibiotic resistance is on the rise. But economically speaking, developing new antibiotics is not in any given pharmaceutical companies best interest.

Read all about “resistance breakers”, “blue-sky” research and innovation funding for antibiotics over at BBC. _66267654_c0134727-salmonella_bacteria,_artwork-spl